1. Market Research
  2. > Pathology
45 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

India Thoracic Surgical Devices Market By Product, By Indication, By End users, By Region, Competition, Forecast & Opportunities, 2025

  • $ 2950
  • May 2020
  • 77 pages

By Indication (Lung Cancer, Lymphoma, Mediastinal tumors, Others) ##. ##. ##.

  • Lymphoma
  • Surgical Equipment
  • India
  • Market Size

India Oral Cancer Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025

  • $ 2000
  • February 2020
  • 40 pages

Lymphomas ##.

  • Cancer
  • Lymphoma
  • Oropharynx Cancer
  • India
  • Market Size

Coronavirus Disease 2019 - Epidemiology Analysis and Forecast - June 2020

  • $ 1995
  • June 2020
  • 38 pages

Coronavirus Disease 2019: Epidemiology Analysis and Forecast - June 2020 June ##, 2020 GDHCHT## Copyright @ GlobalData PLC.

  • Epidemiology
  • Lymphoma
  • Pharmaceutical
  • India
  • United States

Biosimilars in Oncology

  • $ 7995
  • August 2018
  • 154 pages

SINCE ITS APPROVAL IN 1997, ROCHE' S RITUXAN HAS BEEN KEY IN THE NHL TREATMENT PARADIGM, AND FORMS THE BACKBONE OF CHEMOTHERAPY REGIMENS IN ALL THERAPY LINES FOR THE FOUR LARGEST B-CELL NHL INDICATIONS, DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), FOLLICULAR LYMPHOMA (FL), MARGINAL Z

  • Biosimilar
  • Lymphoma
  • Medical Biotechnology
  • Oncology
  • India

Malaria: Epidemiology Forecast to 2027

  • $ 3995
  • November 2018
  • 43 pages

Malaria: Epidemiology Forecast to 2027 Summary Malaria is a vector-borne disease caused by parasites of the genus Plasmodium.Malaria is transmitted through the bite of the female Anopheles mosquito. Upon ...

  • Lymphoma
  • Malaria
  • Pathology
  • India
  • Forecast

2024 India Hematology and Flow Cytometry Analyzers and Reagents Market: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Competitive Landscape, Emerging Technologies, Instrumentation and Opportunities

  • $ 1450
  • July 2020
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • India
  • Demand

Dry Eye Syndrome: Epidemiology Forecast to 2028

  • $ 3995
  • May 2020
  • 35 pages

Dry Eye Syndrome: Epidemiology Forecast to 2028 Summary Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye characterized by dryness, decreased ...

  • Antimalarials
  • Health Services
  • Lymphoma
  • Ophthalmology
  • India

India Hematology and Flow Cytometry Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • September 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • India
  • Demand

India Hematology and Flow Cytometry Analyzers and Reagents Market, 2019-2023: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 750
  • June 2019
  • 225 pages

Flow Cytometry Tests Analyzed in the Report Cell Surface Markers (CD##/ CD##/ TandB Lymphocytes, CD##, Others), Chemotherapy Monitoring (Leukemia/ Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analy

  • Biopharmaceutical
  • Diagnostics
  • Lymphoma
  • Medical Biotechnology
  • India

Global Pharmerging Markets 2017-2021

  • $ 2500
  • January 2017
  • 116 pages

These drugs are expected to work effectively in the treatment of various cancers such as lung cancer, breast cancer, chronic myeloid leukemia and lymphomas.

  • Lymphoma
  • Pharmaceutical
  • India
  • AstraZeneca PLC
  • Novartis AG

MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts

  • $ 5995
  • December 2016
  • 128 pages

WHILE VENTANA OFFERS AN FDA-APPROVED ANAPLASTIC LYMPHOMA KINASE (ALK) IHC TEST FOR LUNG CANCER PATIENTS, ONE KOL THOUGHT THAT SUCH IHC TESTS WERE OF LIMITED WORTH DUE TO THE LACK OF CLINICAL EVIDENCE, AND CONSIDERING THAT NOT EVEN ONE PHYSICIAN REQUESTED AN ALK IHC TEST.

  • Cancer
  • Lymphoma
  • India
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.

Pertussis (Whooping Cough) - Pipeline Review, H2 2019

  • $ 2000
  • December 2019
  • 115 pages

Deleting or neutralizing Clever-## has previously been reported to augment antitumor immune responses in melanoma, lymphoma and breast cancer.

  • Infectious Disease
  • Lymphoma
  • Pathology
  • Vaccine
  • India

Diphtheria - Pipeline Review, H1 2020

  • $ 2000
  • May 2020
  • 85 pages

The company' s pipeline products include BR##, BR##, BR## for treating hypertension; BR2002, a drug used to treat lymphoma; and BR##, a vaccine designed for the treatment of Hepatitis A.

  • Infectious Disease
  • Pathology
  • Vaccine
  • India
  • Sanofi S.A.

Pharmerging Markets 2016-2020

  • $ 2500
  • November 2015
  • 104 pages

lymphoma kinase inhibitor Xalkori In December 2014, the company and OPKO Health entered into a global agreement to develop and commercialize OPKO' s long-acting hGH-CTP, which is used to treat growth hormone deficiency in adults and children In December 2014, Pfizer entered into an agre

  • Lymphoma
  • Pharmaceutical
  • India
  • AstraZeneca PLC
  • GlaxoSmithKline plc

IVD in India

  • $ 4200
  • January 2016
  • 240 pages

EBV has also been implicated as a contributing cause of several more serious diseases including cancer, including Hodgkin' s disease, post-transplant and other lymphomas, nasopharyngeal carcinoma (the most common head and neck cancer in large regions of Asia), breast cancer and Burkitt&

  • In Vitro Diagnostics
  • Infectious Disease
  • Laboratory
  • Lymphoma
  • India

India Diagnostic Imaging Market Outlook to 2025 - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography (CT) Systems and Others

  • $ 5995
  • June 2020
  • 198 pages

LYMPHOMA.

  • CT Scan
  • Diagnostic Imaging
  • Lymphoma
  • India
  • South Asia

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • September 2018
  • 32 pages

This includes many lymphomas, leukemias, transplant rejection, and some autoimmune disorders.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • India
  • Emcure Pharmaceuticals Limited

Cadila Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 26 pages

The company offers products such as VAL-##, which is used in the treatment of diffuse large B-cell lymphoma; RESP- ## and RESP-2000 series, used for the treatment of COPD and asthma; and RESP-##, a biomarker used for cardiovascular PET-imaging.

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • India
  • Cadila Healthcare Ltd

Pertussis (Whooping Cough) - Pipeline Review, H1 2020

  • $ 2000
  • June 2020
  • 127 pages

Deleting or neutralizing Clever-## has previously been reported to augment antitumor immune responses in melanoma, lymphoma and breast cancer.

  • Infectious Disease
  • Lymphoma
  • Vaccine
  • India
  • Sanofi S.A.

GVK Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • November 2018
  • 28 pages

Summary GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing, discovery and development services.The organization’s services include chemistry services, ...

  • Healthcare
  • Lymphoma
  • Pharmaceutical
  • India
  • GVK Biosciences Pvt Ltd
View report >

Global Pharmaceutical Industry

  • January 2019
  • 25 pages

Lupin' s MALT## Oncology program uses a novel compound with the potential to treat multiple hematological cancers which includes ABC Type - Diffuse Large B-Cell Lymphoma (ABC-DLBCL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL), in addition to other B-cell m

  • Lymphoma
  • Pharmaceutical
  • India
  • United States
  • World

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on